Loomis, Sayles & Company
VCYT icon

Loomis, Sayles & Company’s Veracyte VCYT Stock Holding History

Loomis, Sayles & Company’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-409,471
Closed -$11.1M – 766
2025
Q2 		$11.1M Sell
409,471
-73,250
-15% -$2.12M 0.01% 363
2025
Q1 		$14.3M Buy
482,721
+73,019
+18% +$2.78M 0.02% 294
2024
Q4 		$16.2M Buy
+409,702
New +$15.5M 0.02% 289
2021
Q1 		– Sell
-1,065,939
Closed -$52.2M – 898
2020
Q4 		$52.2M Sell
1,065,939
-6,276
-0.6% -$291K 0.07% 127
2020
Q3 		$34.8M Buy
1,072,215
+135,420
+14% +$4.3M 0.05% 148
2020
Q2 		$24.3M Buy
936,795
+212,522
+29% +$5.3M 0.04% 190
2020
Q1 		$17.6M Buy
+724,273
New +$18.2M 0.04% 184

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Loomis, Sayles & Company's VCYT Position: Q3 2025 in Review

Loomis, Sayles & Company sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 409,471 shares — an estimated $11.1M sold.

Loomis, Sayles & Company first reported a position in VCYT in Q1 2020 and held it in 7 quarters. The position peaked at $52.2M in Q4 2020. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Loomis, Sayles & Company reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Loomis, Sayles & Company sold 409,471 Veracyte shares in Q3 2025, an estimated $11.1M.
  • Loomis, Sayles & Company first reported a position in Veracyte in Q1 2020 and held it in 7 quarters.
  • Loomis, Sayles & Company's Veracyte position peaked at $52.2M in Q4 2020.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Loomis, Sayles & Company's 13F filing for Q3 2025, filed 13 Nov 2025.